Joseph A. Pinto

4.0k total citations · 1 hit paper
90 papers, 1.6k citations indexed

About

Joseph A. Pinto is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joseph A. Pinto has authored 90 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 30 papers in Cancer Research and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joseph A. Pinto's work include Breast Cancer Treatment Studies (16 papers), Cancer Genomics and Diagnostics (12 papers) and Lung Cancer Treatments and Mutations (11 papers). Joseph A. Pinto is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), Cancer Genomics and Diagnostics (12 papers) and Lung Cancer Treatments and Mutations (11 papers). Joseph A. Pinto collaborates with scholars based in Peru, United States and Belgium. Joseph A. Pinto's co-authors include Jhajaira M. Araujo, Henry Gómez, Williams Fajardo, Justin M. Balko, Carlos Vallejos, Zaida Morante, Alfredo Aguilar, Luís Más, Luis E. Raez and Claudio Flores and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Joseph A. Pinto

86 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characteristics of gastric cancer around the world

2022 175 citations Alejandro Alfaro, Luis Saravia et al. Critical Reviews in Oncology/Hematology profile →

Peers

Joseph A. Pinto

ONCOL

PRM

IMMUN

Min Huang United States

Bin Xu China

Lu Li China

Bo Chen China

Andrew Redfern Australia

Sara Bravaccini Italy

Francesco Schettini Italy

Cuizhi Geng China

Paul Beckett United Kingdom

Karijn P.M. Suijkerbuijk Netherlands

Min Huang United States

Joseph A. Pinto

735 ×1.0

ONCOL

598 ×1.0

507 ×1.0

422 ×1.0

PRM

198 ×1.1

IMMUN

Citations per year, relative to Joseph A. Pinto Joseph A. Pinto (= 1×) peers Min Huang

Countries citing papers authored by Joseph A. Pinto

Since Specialization

Citations

This map shows the geographic impact of Joseph A. Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Pinto more than expected).

Fields of papers citing papers by Joseph A. Pinto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph A. Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Pinto. The network helps show where Joseph A. Pinto may publish in the future.

Co-authorship network of co-authors of Joseph A. Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Pinto. A scholar is included among the top collaborators of Joseph A. Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Pinto. Joseph A. Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pinto, Joseph A., et al.. (2024). Antibody-Drug Conjugates in Breast Cancer: Toward a Molecular Perspective Into Clinical Practice. JCO Precision Oncology. 8(8). e2400173–e2400173. 6 indexed citations

Araujo, Jhajaira M., Alejandro Alfaro, Williams Fajardo, et al.. (2024). Socioeconomic disparities and the genomic landscape of gastric cancer. Scientific Reports. 14(1). 15070–15070. 1 indexed citations

Pinto, Joseph A., et al.. (2024). Risk factors associated with the mortality of COVID‑19 in patients with type 2 diabetes mellitus. World Academy of Sciences Journal. 6(6). 1 indexed citations

Zevallos, Alejandra, et al.. (2024). Frequency of SARS-CoV-2 variants identified by real-time PCR in the AUNA healthcare network, Peru. Frontiers in Public Health. 11. 1244662–1244662.

Ruiz, Joaquı́m, et al.. (2023). First report of CrpP prevalence in a South American country. New Microbes and New Infections. 51. 101082–101082. 1 indexed citations

Araujo, Jhajaira M., Gabriel De la Cruz Ku, Melanie Cornejo, et al.. (2022). Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes. Cancers. 14(17). 4286–4286. 4 indexed citations

Agarwal, Aarti, et al.. (2022). Feasibility of collagen matrix tiles with cesium-131 brachytherapy for use in the treatment of head and neck cancer. Brachytherapy. 22(1). 120–124.

Pinto, Joseph A., et al.. (2021). Biological bases of cancer immunotherapy. Expert Reviews in Molecular Medicine. 23. e3–e3. 18 indexed citations

Acosta, Óscar, Jaime Ponce, José M. Cotrina, et al.. (2021). PUM1 and RNase P genes as potential cell‐free DNA markers in breast cancer. Journal of Clinical Laboratory Analysis. 35(4). e23720–e23720. 7 indexed citations

10.

Montenegro, Paola, et al.. (2020). Telemedicine and the current opportunities for the management of oncological patients in Peru in the context of COVID-19 pandemic. Critical Reviews in Oncology/Hematology. 157. 103129–103129. 15 indexed citations

11.

Araujo, Jhajaira M., et al.. (2020). Profile of entrectinib in the treatment of ROS1-positive non-small cell lung cancer. Hematology/Oncology and Stem Cell Therapy. 14(3). 192–198. 5 indexed citations

12.

Pinto, Joseph A., et al.. (2020). The impact of COVID-19 in the healthcare workforce in Peru. Journal of Public Health Policy. 42(1). 182–184. 17 indexed citations

13.

Guevara, María L., Óscar Acosta, Joseph A. Pinto, et al.. (2017). Mutational analysis of BRCA 1 and BRCA 2 genes in Peruvian families with hereditary breast and ovarian cancer. Repositorio Académico USMP. 1 indexed citations

14.

Pinto, Joseph A., et al.. (2017). History of the development of radiotherapy in Latin America. ecancermedicalscience. 11. 784–784. 9 indexed citations

15.

Castañeda, Carlos A., Marco López-Ilasaca, Joseph A. Pinto, et al.. (2014). PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers. Hematology/Oncology and Stem Cell Therapy. 7(4). 142–148. 19 indexed citations

16.

Dennison, Jennifer B., Jennifer R. Molina, Shreya Mitra, et al.. (2013). Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer. Clinical Cancer Research. 19(13). 3703–3713. 93 indexed citations

17.

Gómez, Henry, Frank Campana, Silvia P. Neciosup, et al.. (2012). Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma. Hematology/Oncology and Stem Cell Therapy. 5(3). 152–157. 1 indexed citations

18.

Gómez, Henry, Joseph A. Pinto, Mivael Olivera, et al.. (2010). Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancer. The Breast. 20(1). 39–45. 7 indexed citations

19.

Vallejos, Carlos, Henry Gómez, Joseph A. Pinto, et al.. (2010). Breast Cancer Classification According to Immunohistochemistry Markers: Subtypes and Association With Clinicopathologic Variables in a Peruvian Hospital Database. Clinical Breast Cancer. 10(4). 294–300. 112 indexed citations

20.

Gómez, Henry, Carlos A. Castañeda, Carlos E. Vigil, et al.. (2010). Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients. Hematology/Oncology and Stem Cell Therapy. 3(3). 109–115. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact